US equities drop as dollar and oil prices fall


In contrast to European markets US equities were falling at the open as the dollar is falling and crude prices slump.

Around US$1.5mln was erased from worlwide shares last week in a mighty volatile few days. This week has started with the benchmark Dow down 56 points  the Nasdaq down 37 and the S&P 500 losing 11 points to stand at 1894.

Also in the mix is Fed comments over the weekend after last week's IMF  global growth forecasts cut  which suggested the international slowdown in the economny could lead to US rate rises being delayed.

Unease about global growth saw the US dollar today decline 0.4 percent against the yen and fall 0.5% against the Euro.

In London Footsie is currently up over 27 points to 6361 with  miners still doing well - boosted by positive export data from China.

The  biggest rocket was Synergy Health (LON:SYR) which surged 32% after US group Steris Corp offered US$1.9bn in a cash and shares deal. 

The biggest laggard was electronic  chip designer ARM Holdings (LON:ARM) down 3.50%.

In the small cap sector things were not quite so upbeat.

One of the most notable gainers was Premier African Minerals (LON:PREM) which added 4.55% after it published a revised study for RHA tungsten project in Zimbabwe.

The preliminary economic assessment prepared by Bara Consulting has almost doubled the estimated value of the mine.

The net present value is put at US$183mln compared to US$99mln while the life of the operation has been extended to 15 years from six.

Also rising in the mining sector was recovcery specialist  Goldplat (LON:GDP) which gained 7.14% in morning deals.

Closely followed outsource group Quindell (LON:QPP) lost 6.65% despite saying it  was on track to hit the upper end of full-year target ranges after a strong third quarter.

Revenue in the third quarter more than doubled to around £198mln from £92.1mln a year earlier due largely to strong organic growth and synergies from acquisitions filtering through.

Adjusted underlying earnings (EBITDA) shot up to around £83mln from £34.5mln in the third quarter of last year while the adjusted EBITDA margin rose to 42% the upper end of guidance from 36% in the same quarter of 2013.


ProactiveInvestors - UK

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.